Nathaniel S. Gardiner
2016
In 2016, Nathaniel S. Gardiner earned a total compensation of $1.1M as Senior Vice President and General Counsel at Enanta Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $116,764 |
---|---|
Option Awards | $505,986 |
Salary | $353,403 |
Stock Awards | $94,175 |
Other | $15,857 |
Total | $1,086,185 |
Gardiner received $506K in option awards, accounting for 47% of the total pay in 2016.
Gardiner also received $116.8K in non-equity incentive plan, $353.4K in salary, $94.2K in stock awards and $15.9K in other compensation.
Rankings
In 2016, Nathaniel S. Gardiner's compensation ranked 7,846th out of 14,075 executives tracked by ExecPay. In other words, Gardiner earned more than 44.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,846 | 44th |
Manufacturing | 2,984 | 46th |
Chemicals And Allied Products | 990 | 48th |
Drugs | 767 | 50th |
Pharmaceutical Preparations | 609 | 48th |
Gardiner's colleagues
We found four more compensation records of executives who worked with Nathaniel S. Gardiner at Enanta Pharmaceuticals in 2016.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019